logo
Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH

Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH

Yahoo20 hours ago
Bagsværd, Denmark, 15 August 2025 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved an additional indication for Wegovy® (semaglutide 2.4 mg) based on a supplemental New Drug Application (sNDA) for treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), in combination with a reduced calorie diet and increased physical activity.
The accelerated approval is based on part 1 of the ESSENCE trial, in which Wegovy® demonstrated a statistically significant and superior improvement in liver fibrosis with no worsening of steatohepatitis, as well as resolution of steatohepatitis with no worsening of liver fibrosis compared to placebo.
The clinical data from ESSENCE showed that at week 72, 36.8% of people treated with Wegovy® achieved improvement in liver fibrosis with no worsening of steatohepatitis compared to 22.4% treated with placebo. 62.9% of people treated with Wegovy® achieved resolution of steatohepatitis with no worsening of liver fibrosis compared to 34.3% treated with placebo.
'Wegovy® is now uniquely positioned as the first and only GLP-1 treatment approved for MASH, complementing the already proven weight loss, cardiovascular benefits and extensive body of evidence linked to semaglutide,' said Martin Holst Lange, executive vice president, chief scientific officer and head of Research and Development, at Novo Nordisk. 'MASH represents a significant health burden, with one in three people with overweight or obesity worldwide affected. In the US alone, around 22 million people are estimated to live with MASH. With the approval of Wegovy® for MASH, we provide a new treatment to people living with MASH that not only halts the disease activity but helps reverse the damage caused to the liver.'
As of today, Wegovy® is available in the US for the treatment for MASH.
About MASH Metabolic dysfunction-associated steatohepatitis (MASH) is a serious, progressive, metabolic disease affecting the liver, which can be fatal if not properly managed. More than 250 million people live with MASH and the number of individuals in advanced stages of the disease is expected to double by 2030. Of those who are currently overweight or living with obesity, more than one in three are also living with MASH. People living with MASH often experience few or no specific symptoms in the early stages of the disease, which often results in delayed diagnosis. The risk of progression to advanced liver disease, including liver cancer, is higher in people living with MASH than in the general population.
About the ESSENCE trial ESSENCE is a phase 3 trial evaluating the effect of once-weekly subcutaneous semaglutide 2.4 mg in adults with metabolic dysfunction-associated steatohepatitis with moderate to advanced liver fibrosis (stage 2 or 3). ESSENCE is a two-part trial where 1,200 planned participants were randomised 2:1 to receive semaglutide 2.4 mg or placebo, on top of standard of care for 240 weeks. In part 1, the objective was to demonstrate that treatment with semaglutide 2.4 mg improves liver histology at 72 weeks based on biopsy sampling from the first 800 randomised patients. In part 2, the objective is to demonstrate that treatment with semaglutide 2.4 mg lowers the risk of liver-related clinical events compared to placebo in adults with MASH and moderate to advanced liver fibrosis at 240 weeks.
Based on part 1 of the ESSENCE trial, Novo Nordisk has also filed for regulatory approval in the EU in February 2025, with a subsequent filing in Japan in May 2025. Part 2 of the ESSENCE trial is expected to read out in 2029.
About Wegovy® (semaglutide 2.4 mg) The FDA initially approved Wegovy® in 2021 with a reduced calorie meal plan and increased physical activity to help adults with obesity, or adults with excess weight (overweight) who also have weight-related medical problems to lose weight and keep the weight off. The indication was expanded in 2022 to include children aged 12 years and older with obesity. In 2024, Wegovy® was approved to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and either obesity or overweight. Today, the FDA granted accelerated approval for Wegovy® for a new patient population for the treatment of MASH in adults with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver.
About Novo Nordisk Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease. Novo Nordisk employs about 78,400 people in 80 countries and markets its products in around 170 countries. Novo Nordisk's B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk.com, Facebook, Instagram, X, LinkedIn and YouTube.
Contacts for further information:
Media:
Ambre James-Brown +45 3079 9289abmo@novonordisk.com
Liz Skrbkova (US)+1 609 917 0632lzsk@novonordisk.com
Investors:
Jacob Martin Wiborg Rode +45 3075 5956 jrde@novonordisk.com
Sina Meyer +45 3079 6656 azey@novonordisk.com
Frederik Taylor Pitter (US) +1 609 613 0568 fptr@novonordisk.com
Max Ung +45 3077 6414 mxun@novonordisk.com
Publication of inside information pursuant to Market Abuse Regulation, Article 17.
Attachment
CA250815-MASH-US-label-update
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Senate Democrat rips Costco for ‘refusing to sell' abortion pills
Senate Democrat rips Costco for ‘refusing to sell' abortion pills

The Hill

time2 hours ago

  • The Hill

Senate Democrat rips Costco for ‘refusing to sell' abortion pills

Sen. Patty Murray (D-Wash.) hammered Costco on Friday for appeasing 'far-right extremists,' after the retailer said earlier this week that its pharmacies would not dispense the abortion medication mifepristone. 'I am deeply alarmed by news reports that Costco is refusing to sell safe, effective, and legal medication for no other reason than to appease the politics of anti-abortion fanatics,' Murray said in a statement following the news. 'I refuse to stand by and allow far-right extremists to bully major corporations and dictate what medicine women can or cannot get access to.' 'Where it is legal, retailers and major pharmacies must absolutely make medication abortion available to the women who need it,' the Washington Democrat added. Costco, in its Thursday announcement, explained that the decision came from a 'lack of demand.' 'Our position at this time not to sell mifepristone, which has not changed, is based on the lack of demand from our members and other patients, who we understand generally have the drug dispensed by their medical providers,' the company said, according to Reuters. The decision comes after CVS and Walgreens announced last year that they received certification to provide the drug in states where abortion remains legal. Murray pressed Costco to rescind its decision, warning that limiting access to mifepristone, one of two drugs used in medication abortion, is harmful to women's health. 'Mifepristone is safe and effective—we cannot live in a world where the availability of women's health care whipsaws back and forth based on the whims of extremists who want to deny women access to basic health care,' she wrote Friday. 'I am demanding that Costco immediately reverse course—follow the science and the facts, not the demands of far-right anti-abortion extremists.' The Supreme Court in a decision last year ruled unanimously that a group of anti-abortion doctors did not have the legal basis to challenge access to the pill. Despite the ruling, Health and Human Services Secretary Robert F. Kennedy Jr. and Food and Drug Administration (FDA) Commissioner Marty Makary are weighing a review of the abortion pill. Murray questioned Makary during his Senate confirmation hearing on the proposal, as well as President Trump's moves to gut staff at the FDA.

Modern medicine has its scientific roots in the Middle Ages − how the logic of vulture brain remedies and bloodletting lives on today
Modern medicine has its scientific roots in the Middle Ages − how the logic of vulture brain remedies and bloodletting lives on today

Yahoo

time4 hours ago

  • Yahoo

Modern medicine has its scientific roots in the Middle Ages − how the logic of vulture brain remedies and bloodletting lives on today

Nothing calls to mind nonsensical treatments and bizarre religious healing rituals as easily as the notion of Dark Age medicine. The 'Saturday Night Live' sketch Medieval Barber Theodoric of York says it all with its portrayal of a quack doctor who insists on extracting pints of his patients' blood in a dirty little shop. Though the skit relies on dubious stereotypes, it's true that many cures from the Middle Ages sound utterly ridiculous – consider a list written around 800 C.E. of remedies derived from a decapitated vulture. Mixing its brain with oil and inserting that into the nose was thought to cure head pain, and wrapping its heart in wolf skin served as an amulet against demonic possession. 'Dark Age medicine' is a useful narrative when it comes to ingrained beliefs about medical progress. It is a period that stands as the abyss from which more enlightened thinkers freed themselves. But recent research pushes back against the depiction of the early Middle Ages as ignorant and superstitious, arguing that there is a consistency and rationality to healing practices at that time. As a historian of the early Middle Ages, roughly 400 to 1000 C.E., I make sense of how the societies that produced vulture medicine envisioned it as one component of a much broader array of legitimate therapies. In order to recognize 'progress' in Dark Age medicine, it is essential to see the broader patterns that led a medieval scribe to copy out a set of recipes using vulture organs. The major innovation of the age was the articulation of a medical philosophy that validated manipulating the physical world because it was a religious duty to rationally guard the body's health. Reason and religion The names of classical medical innovators like Hippocrates and Galen were well known in the early Middle Ages, but few of their texts were in circulation prior to the 13th century. Most intellectual activities in northern Europe were taking place within monasteries, where the majority of surviving medical writings from that time were written, read, discussed and likely put into practice. Scholars have assumed that religious superstition overwhelmed scientific impulse and the church dictated what constituted legitimate healing – namely, prayer, anointing with holy oil, miracles of the saints and penance for sin. However, 'human medicine' – a term affirming human agency in discovering remedies from nature – emerged in the Dark Ages. It appears again and again in a text monks at the monastery of Lorsch, Germany, wrote around the year 800 to defend ancient Greek medical learning. It insists that Hippocratic medicine was mandated by God and that doctors act as divine agents in promoting health. I argue in my recent book, 'Embodying the Soul: Medicine and Religion in Carolingian Europe,' that a major innovation of that time was the creative synthesis of Christian orthodoxy with a growing belief in the importance of preventing disease. Establishing an intellectual framework for medical study was an accomplishment of early medieval scholars. Doctors faced the risk of being lumped together with those who dealt in sorcery and pagan folklore, a real possibility given that the men who composed the Greek medical canon were pagans themselves. The early medieval scribes responsible for producing the medical books of their age crafted powerful arguments about the respectability and piety of the doctor. Their arguments manifest in illustrations that sanctified the human doctor by setting him parallel to Christ. This sanctification was a crucial step in including medicine as its own advanced degree program at the first universities that were established around 1200 in Europe. Thus began the licensing of healers: the elite 'phisici' – the root of the English word 'physician' – trained at the university, along with empirical practitioners like surgeons, herbalists and female healers who claimed a unique authority to treat gynecological illnesses. Today, religious dogmatism is often equated with vaccine hesitancy and resistance to basic scientific truths like evolution. But deeply religious thinkers of the past often saw rational medicine as an expression of faith, not something endangering it. Herbal remedies were scribbled into the margins of early medieval works on theology, history, church sacraments and more. This suggests that book owners valued such knowledge, and people of all classes were actively exchanging recipes and cures by word of mouth before writing the most useful ones down. The body in nature Though the Dark Ages is a period from which no case histories survive, we can still form a picture of an average healing encounter. Texts from that period emphasize the need for the doctor to be highly learned, including being well read in philosophy, logic, arithmetic and astronomy. Such knowledge enabled healers to situate their observations of sick bodies within the rules that governed the constant transformations of nature. There was no way to perceive the internal state of the body via technology – instead, healers had to be excellent listeners and observers. They sought to match the patient's description of suffering with signs that manifested externally on the body. The inside of the flesh could not be seen, but the fluids the body excreted – sweat, urine, menstrual blood, mucus, vomit and feces – carried messages about that invisible realm to the outside. The doctor's diagnosis and prognosis relied on reading these 'excreta' in addition to sensing subtle changes in the pulse. Medieval people were detailed investigators of the natural world and believed the same forces that shaped the landscape and the stars operated inside bodies formed from the same four elements of earth, water, air and fire. Thus, as the moon's waxing and waning moved the ocean tides, so did it cause humors inside the body to grow and decrease. The way the seasons withered crops or provoked tree sap to flow might manifest in the body as yellow bile surging in the summer, and cold, wet phlegm dripping in the winter. Just as fruit and meats left untouched began to rot and putrefy, so did dregs and undigested material inside the body turn poisonous if not expelled. Standing water in ponds or lakes generated slime and smell, and so were liquids sitting stagnant in the body's vessels seen as breeding grounds for corrupt vapors. In this sense, the menstrual cycle was representative of all bodies, undergoing internal transformations according to seasonal cycles and periodically purged in order to release pent-up fluids. According to this logic, health depended above all on maintaining the body's relationship to the physical environment and ensuring that substances were passing through their proper transformations, whether it was food turning into humors, blood disseminating throughout the body, or excess fluids and wastes leaving the body. Bloodletting was a rational therapy because it could help rebalance the fluids and remove toxins. It was visible and tangible to the patient, and, to the extent that we now better understand the placebo effect, it may well have offered some kind of relief. Fasting, purging, tonics and, above all, monthly dietary regimens were also prominent tools healers used to prevent and relieve sickness. Several medical books, for instance, specified that consuming drinks with cinnamon in November and pennyroyal in August could recalibrate the body's temperature in winter and summer because one drink was warming while the other was cooling. Some medieval remedies – such as one produced from wine, cow bile, garlic and onion to heal eye infections – were later proven to be likely effective in treating sickness. But whether these remedies worked isn't the point. For medieval doctors, vulture brains and cow bile operated according to the same logic that continues to inform research today: Nature operates in mysterious ways, but rational deduction can unlock the hidden mechanisms of disease. The M.D. has direct roots in the Dark Age elevation of 'human medicine.' Before mocking medieval doctors, consider how popular juice cleanses and detox regimens are in the 21st century. Are we really so far from humoral medicine today? This article is republished from The Conversation, a nonprofit, independent news organization bringing you facts and trustworthy analysis to help you make sense of our complex world. It was written by: Meg Leja, Binghamton University, State University of New York Read more: Poison or cure? Traditional Chinese medicine shows that context can make all the difference Medieval illustrated manuscripts reveal how upper-class women managed healthy households – overseeing everything from purging, leeching and cupping to picking the right wet nurse Medieval medical books could hold the recipe for new antibiotics Meg Leja does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

What You Need to Know About Kratom
What You Need to Know About Kratom

Wall Street Journal

time6 hours ago

  • Wall Street Journal

What You Need to Know About Kratom

Millions of Americans take the herbal supplement kratom for everything from energy to pain relief to quitting opioids. You can find kratom capsules, powder, drinks and shots in health food stores, gas stations and smoke shops. But the Food and Drug Administration is pushing to effectively ban a kratom derivative known as 7-OH, citing its potential for abuse. Some doctors and substance-abuse counselors warn that there are signs the plant itself is potentially addictive. Users contend it confers pain and mood-related benefits and provides an alternative to opioids.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store